Variant Synonymizer: Platform to identify mutations defined in different ways is available now!
Over 2,000 gene–disease validation summaries are now available—no login required!
C1QBP encodes complementary C1q-binding protein (p32), a mitochondrial matrix protein essential for oxidative phosphorylation. A homozygous c.823C>T (p.Leu275Phe) variant in C1QBP was identified in two Chinese siblings presenting with exercise intolerance and ptosis, leading to early-onset combined oxidative phosphorylation deficiency under an autosomal recessive inheritance mode (PMID:33344382). Parents were heterozygous carriers without clinical manifestations, supporting segregation.
Functional studies of HABP1 (p32) truncating variants in COS-1 cells demonstrated that disruption of trimeric assembly induces autophagic vacuolation and F-actin disassembly, underscoring p32’s role in mitochondrial homeostasis and stress responses (PMID:15005653). A recent review consolidates C1QBP deficiency phenotypes—including mitochondrial cardiomyopathy, external ophthalmoplegia, and combined oxidative phosphorylation defects—observed in autosomal recessive cases, confirming loss-of-function as a disease mechanism (PMID:35310974).
Key Take-home: Biallelic loss-of-function variants in C1QBP cause autosomal recessive mitochondrial disease, guiding targeted genetic diagnosis and management of combined OXPHOS deficiencies.
Gene–Disease AssociationLimitedHomozygous c.823C>T (p.Leu275Phe) in two siblings from one family; autosomal recessive inheritance with parental segregation; no additional unrelated cases. Genetic EvidenceLimitedOne missense variant reported in 2 probands; minimal segregation beyond sib pair. Functional EvidenceModerateIn vitro truncation assays recapitulate mitochondrial stress phenotypes; review of multiple models confirms loss-of-function mechanism. |